Atkinson Edward Morrow Iii Insider Trades

Insider Trading History

Track insider trading activity for Atkinson Edward Morrow Iii. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $8.63M 18,432 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$325k 668 shares
$486.35
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $8.94M 19,100 shares
Last Trade
Feb 24, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$789k 1,627 shares
$485.11
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $9.71M 20,727 shares
Last Trade
Feb 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$387k 817 shares
$473.68
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $10.1M 21,544 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$994k 2,031 shares
$489.46
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $11.8M 25,105 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.37M 4,962 shares
$477.40
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $11M 23,575 shares
Last Trade
Feb 17, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$740k 1,530 shares
$483.75
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $9.43M 20,143 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$928k 1,903 shares
$487.76
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $10.3M 22,046 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$806k 1,751 shares
$460.43
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $11.1M 23,797 shares
Last Trade
Feb 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$408k 872 shares
$468.41
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $11.6M 24,669 shares
Last Trade
Jan 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81M 3,883 shares
$467.35
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $9.73M 20,786 shares
Last Trade
Jan 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.84M 3,934 shares
$467.35
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $7.89M 16,852 shares
Last Trade
Nov 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.09M 2,500 shares
$434.58
$468.28
89bio
89bio ETNB
Director
Holding Value $0 0 shares
Last Trade
Oct 30, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$670k 45,150 shares
$14.84
$14.84
89bio
89bio ETNB
Director
Holding Value $0 0 shares
Last Trade
Oct 30, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$297k 20,000 shares
$14.84
$14.84
89bio
89bio ETNB
Director
Holding Value $0 0 shares
Last Trade
Oct 30, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$837k 56,400 shares
$14.84
$14.84
89bio
89bio ETNB
Director
Holding Value $0 0 shares
Last Trade
Oct 30, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$403k 27,400 shares
$14.70
$14.84
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $9.06M 19,352 shares
Last Trade
Feb 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.26M 2,650 shares
$475.34
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $10.3M 22,002 shares
Last Trade
Feb 26, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.19M 2,482 shares
$479.61
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $11.5M 24,484 shares
Last Trade
Feb 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$850k 1,767 shares
$480.95
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Technical Ops. Off.
Holding Value $12.3M 26,251 shares
Last Trade
Feb 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$800k 1,656 shares
$483.28
$468.28

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up